Status:
WITHDRAWN
HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers
Lead Sponsor:
Medical University of Vienna
Conditions:
Sars-CoV2
Infection Viral
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Background: Aim: To demonstrate the efficacy of low-dose hydroxychloroquine as primary prevention in healthcare workers Design, participants and interventions: Prospective, randomized, parallel group...
Eligibility Criteria
Inclusion
- Health-care worker with frequent contact with confirmed COVID-19 patients
- No active or past infection with SARS-CoV-2
- 18 years of age or older
- No allergy or contraindication to hydroxychloroquine
- written informed consent
Exclusion
- Age of less than 18 years
- Pregnancy or lactation
- unwillingness to use effective contraception during the participation in the trial
- Use of concomitant medication that prolongs the QT interval
- Allergy or contraindication to hydroxychloroquine
- Retinopathy or maculopathy
- Neuromuscular diseases (i.e Myasthenia gravis, Parkinson's disease)
- G6PD Deficiency
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04336748
Start Date
April 1 2020
End Date
August 1 2020
Last Update
April 12 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.